Antipsychotics

Everything

Autistic People Against Neuroleptic Abuse
www.dinahm.pwp.blueyonder.co.uk
| home | letters | personal | interview | views | you&yours | legal opinion | risperidone | links | email | DISCLAIMER Material herein is reported in condensed form from bulletins, manufacturers' data sheets, patient information leaflets, research

Risperdal.com
www.risperdal.com
Risperdal information at Risperdal.com Contact Risperdal Search this site: Janssen Pharmaceuticals, Inc. is initiating a voluntary recall of one lot of RISPERDAL® (risperidone) 3mg Tablets, marketed by Janssen Pharmaceuticals, Inc. and one lot of risperidone 2mg Tablets, marketed by Patriot

AstraZeneca E-mails Show Debate on Seroquel Risks
www.dddmag.com
Marketing executives at British drugmaker AstraZeneca PLC for years blocked efforts by company scientists to raise concerns antipsychotic drug Seroquel caused weight gain and other problems, saying that would harm sales, plaintiff lawyers say.

Datamonitor: APA 2010 - Merck and Dainippon take center stage to present new schizophrenia therapies
www.prlog.org | Jun 14, 2010
Datamonitor: APA 2010 - Merck and Dainippon take center stage to present new schizophrenia therapies. Schizophrenia played a prominent role at this year's American Psychiatric Association Annual Meeting due to the prevailing high level of unmet need.

Time-dependent effect analysis of antipsychotic treatment in a naturalistic cohort study of
www.em-consulte.com
European Psychiatry - Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le jeudi 16 juin 2011 - Time-dependent effect analysis of antipsychotic treatment in a naturalistic cohort study of patients with schizophrenia - EM|consulte

Schizophrenia News and Features Page
www.webmd.com
Schizophrenia affects an estimated 2.2 million Americans each year. Here you'll find in-depth schizophrenia information including drugs and other treatments, as well as its causes and symptoms.

Antipsychotic switch | 6minutes
www.6minutes.com.au | Jul 20, 2011
Switching is possible from an antipsychotic with a high metabolic risk to one with a lower risk, a new study shows.

Johnson Johnson to Pay 158 Million to Settle Texas
www.biospace.com | Jan 20, 2012
Johnson & Johnson said on Thursday it will pay $158 million to settle a Texas lawsuit accusing the drugmaker of improperly marketing its Risperdal

Dr. Reddy's Laboratories' CEO Discusses Q3 2012 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com | Feb 3, 2012
< p > Dr. Reddy's Laboratories ( < a href='http://seekingalpha.com/symbol/rdy' title='Dr. Reddy & #39;s Laboratories Limited' > RDY < /a > ) < /p > < p > Q3 2012 Earnings Call < /p > < p > February 03, 2012 8:00 am ET < /p > < p > < strong > Executives < /strong > < /p > < p > Kedar Upadhye -

Medical News: Drugging Dementia Patients Serious Problem, Panel Says - in Geriatrics, Dementia from
www.medpagetoday.com | Dec 9, 2010
WASHINGTON -- As baby boomers age, the nation faces a crisis in care for an ever-expanding population of dementia patients and over-medication will be a big problem, panelists said at a Senate Aging C